Novo Nordisk stock toppled Monday after its weight-loss pill failed to significantly slow the progression of Alzheimer's ...

Pharma major Novo Nordisk's stock plummeted a record 12.4% on 24 November after the Danish company's weight-loss pill Ozempic ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

The market for GLP-1 medications is already huge, and is expected to explode. It was valued at about $52 billion in 2024; ...

Plus, one peer-reviewed study (which was funded by Nutrafol), found that women who reported hair thinning noticed improved ...

The Target-D clinical trial recruited 630 adults with heart disease from April 2017 to May 2023 About 78 percent of ...

Dermatologists’ growing interest in training comes amid broader growth in integrative medicine — and uncertainties about ...

The number of people taking vitamins, minerals and supplements has risen drastically in the UK. But it isn't just about what ...

Struggling to get your iron levels back on track? You're not alone. Despite taking supplements, many of us still experience ...

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?